FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Cambridge, Massachusetts

Biotech startups in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset
Biotech startups in Cambridge, Massachusetts
One-time CSV
  • 272 funded companies, 237 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~cambridge-massachusetts.csv272 rows × 18 columns
CompanyCityLast roundAmountDate
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
ConcertAICambridgeSeries C$150.0M2022-03-29
Biobot AnalyticsCambridgeSeries A$13.4M2025-06-06
Dyno TherapeuticsCambridgeSeries A$100.0M2021-05-06
InariCambridgeSeries G$144.0M2025-01-07
Cognito TherapeuticsCambridgeSeries C$105.0M2026-03-05
Terrestrial BioCambridgeSeries C$50.0M2026-03-26
SimnovaCambridgeSeries B$59.3M2026-08-18

8 rows of the CSV in 5 of its 18 columns.

272
Startups
$19.8B
Total raised
38
Funded in the last 12 months
$1.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

25 of 272
25 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Elemental Machines Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. Artificial intelligence Series B $5.7M 2026-05-27 $66.5M Founders Fund, Tau Ventures, Rock Health Capital +2 11 to 50 2015
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Stata DX Stata DX develops eRapid disease management technology for implementing custom biomarker panels in clinical studies. Biotech Series A $400K 2026-02-27 $3.6M MassVentures 1 to 10 2022
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
Prudentia Sciences Prudentia Sciences provides AI-powered asset diligence and valuation to reduce risk in drug development investment. Artificial intelligence Series A $20.0M 2026-01-07 $27.0M Google Ventures, Iaso Ventures, Virtue 1 to 10 2023
STRM.BIO STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. Biotech Seed $8.0M 2026-01-07 $10.1M Bill & Melinda Gates Foundation, NYBC Ventures, NCATS 11 to 50 2019
NeuroBionics NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. Biotech Seed $4.2M 2025-12-10 $9.2M MedTech Innovator, Dolby Family Ventures, GreyMatter +1 1 to 10 2023
Kano Therapeutics Kano Therapeutics develops single-stranded DNA for targeted gene correction. Biotech Seed $5.0M 2025-11-07 $7.1M Metaplanet, Taihill Venture, Vsquared Ventures +2 1 to 10 2021
Biobot Analytics Biobot Analytics offers a wastewater data platform that delivers population-level health insights. Artificial intelligence Series A $13.4M 2025-06-06 $41.4M Y Combinator, Pioneer Fund, Soma Capital +2 11 to 50 2017
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
Insilico Medicine Insilico Medicine develops an AI platform for drug development targeting cancer and age-related diseases. Artificial intelligence Series E $123.0M 2025-03-13 $624.3M Qiming Venture Partners, F-Prime, Warburg Pincus +1 101 to 250 2014
Inari Unicorn Inari is a seed design and biotechnology company developing seeds for a nature-positive food system. Biotech Series G $144.0M 2025-01-07 $753.0M EDBI, Alexandria Venture Investments, CPP Investments +2 251 to 500 2016
Nabla Bio Nabla Bio uses an autoverse platform of biologically informed machine learning to co-develop antibody drugs. Artificial intelligence Series A $26.0M 2024-05-14 $37.4M Y Combinator, Khosla Ventures, National Science Foundation +2 11 to 50 2020
NextPoint Therapeutics NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. Biotech Series B $42.5M 2024-02-14 $122.5M Invus, Leaps by Bayer, Catalio Capital Management +2 51 to 100 2020
Elemind Technologies Elemind Technologies develops neuromodulation techniques that shape brainwaves and change brain states. Biotech Seed $12.0M 2024-02-06 $12.0M Village Global, E14 Fund, Evolution VC Partners +2 11 to 50 2019
Nvelop Therapeutics Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. Biotech Seed $100.0M 2023-09-20 $100.0M F-Prime, Atlas Venture, 5AM Ventures +1 51 to 100 2022
ROME Therapeutics ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. Biotech Series B $72.0M 2023-09-12 $199.0M Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 11 to 50 2020
Luminopia Luminopia develops digital treatments for significant neuro-visual disorders. Biotech Series A $16.0M 2023-06-27 $33.1M MassChallenge, U.S. Venture Partners, Bantam Group +2 11 to 50 2015
InsideTracker InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. Biotech Series B $15.0M 2022-09-06 $18.2M OurCrowd, MassVentures, Puget Sound Venture Club +2 11 to 50 2009
ConcertAI Unicorn ConcertAI sells AI-powered SaaS data tools for medical research in oncology. Artificial intelligence Series C $150.0M 2022-03-29 $300.0M Maverick Ventures, Sixth Street, Declaration Partners +2 1,001 to 5,000 2018
Dyno Therapeutics Dyno Therapeutics uses artificial intelligence to develop gene therapies. Artificial intelligence Series A $100.0M 2021-05-06 $109.0M Andreessen Horowitz, Google Ventures, CRV +2 101 to 250 2018

Table 1. Biotech startups in Cambridge, Massachusetts: the 25 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 272.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
2 Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
3 Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
4 Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
5 Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
6 Prudentia Sciences Prudentia Sciences provides AI-powered asset diligence and valuation to reduce risk in drug development investment. Artificial intelligence Series A $20.0M 2026-01-07 $27.0M Google Ventures, Iaso Ventures, Virtue 1 to 10 2023
7 STRM.BIO STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. Biotech Seed $8.0M 2026-01-07 $10.1M Bill & Melinda Gates Foundation, NYBC Ventures, NCATS 11 to 50 2019
8 Elemental Machines Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. Artificial intelligence Series B $5.7M 2026-05-27 $66.5M Founders Fund, Tau Ventures, Rock Health Capital +2 11 to 50 2015
9 NeuroBionics NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. Biotech Seed $4.2M 2025-12-10 $9.2M MedTech Innovator, Dolby Family Ventures, GreyMatter +1 1 to 10 2023
10 Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 2. Biotech startups in Cambridge, Massachusetts: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 F-Prime Venture capital firm Cambridge, United States 6 2% 1 Nocion Therapeutics
2 Alexandria Venture Investments Venture capital firm Pasadena, United States 5 2% 1 Kytopen
3 RA Capital Management Startup incubator Boston, United States 5 2% 1 Terrestrial Bio
4 Y Combinator Startup accelerator Mountain View, United States 4 1%
5 ARCH Venture Partners Venture capital firm Chicago, United States 4 1%
6 The Engine Venture capital firm Cambridge, United States 3 1% 2 Kytopen, Terrestrial Bio
7 Andreessen Horowitz Venture capital firm Menlo Park, United States 3 1%
8 Google Ventures Corporate venture arm San Francisco, United States 3 1% 1 Prudentia Sciences
9 National Science Foundation Entrepreneurship program Alexandria, United States 3 1% 1 Kytopen
10 MassVentures Venture capital firm Boston, United States 3 1% 2 Kytopen, Stata DX
11 Deerfield Hedge fund New York, United States 2 1%
12 Soma Capital Venture capital firm San Francisco, United States 2 1%
13 Lux Capital Venture capital firm New York, United States 2 1% 1 Atavistik Bio
14 Flagship Pioneering Venture capital firm Cambridge, United States 2 1%
15 Casdin Capital Venture capital firm New York, United States 2 1%

Table 3. Biotech startups in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 243 89% $18.7B
Software 45 17% $2.4B
Artificial intelligence 31 11% $2.0B
Hardware 6 2% $406.0M
Fintech 1 0% $155K

Table 4. Biotech startups in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 13 5% $200K
Seed 66 24% $2.6M
Series A 90 33% $39.0M
Series B 68 25% $50.0M
Series C 23 8% $73.9M
Series D+ 12 4% $75.0M

Table 5. Biotech startups in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 3% $15.0M
October 2026 1 3% $150.0M
September 2026 4 11% $62.3M
August 2026 4 11% $256.0M
June 2026 5 13% $270.5M
May 2026 2 5% $127.7M
April 2026 3 8% $101.6M
March 2026 7 18% $313.1M
February 2026 1 3% $400K
January 2026 8 21% $234.5M
December 2025 2 5% $4.4M

Table 6. Biotech startups in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 36 13% $1.5B
2025 31 11% $1.7B
2024 19 7% $881.5M
2023 27 10% $1.7B
2022 28 10% $1.3B
2021 25 9% $1.6B

Table 7. Biotech startups in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 26 10%
2020 to 2022 70 26%
2015 to 2019 99 37%
2010 to 2014 39 14%
Before 2010 36 13%

Table 8. Biotech startups in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 84 31%
11 to 50 131 49%
51 to 100 36 13%
101 to 250 10 4%
251 to 500 3 1%
501 to 1,000 1 0%
1,001 to 5,000 2 1%
10,001 or more 2 1%

Table 9. Biotech startups in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Cambridge, Massachusetts are on the list?
272, in the file dated 16 November 2026. 38 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 272 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Cambridge, Massachusetts: 272 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Cambridge, Massachusetts by funding stage

Other sectors in Cambridge

Biotech startups elsewhere

Cite: FundingWatcher, 272 funded biotech companies in Cambridge, Massachusetts, 16 November 2026. https://fundingwatcher.com/startups/biotech/cambridge-massachusetts/